Impact of Kegel Exercise on Patient Outcomes Post TURP

July 29, 2025 updated by: Hazem Tarraf Abo Dief, Assiut University

Impact of Kegel Exercises on the Postoperative Outcomes of Patients Undergoing Transurethral Resection of the Prostate

how kegel exercise will improve patient outcomes by reducing post TURP LUTs , improve patient performance status and improve patient self esteem

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

patients will divided in to two group study and control, study group will perform kegel exercise postoperative and follow patient progress at 1, 3,6 month while control group receive routine care

Study Type

Interventional

Enrollment (Estimated)

92

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • patient diagnosed with BPH and undergoing TURP
  • Patient age range from 45-65years old
  • Patient understand verbal and written instructions

Exclusion Criteria:

Patient confirmed diagnosis with prostate cancer (biopsy-PSA) Conversion to open prostatectomy Patient has cognitive impairment Patient has chronic cough /chronic bronchitis or asthma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: kegel exercise
kegel exercise improve muscles strength
this exercise used to improve urine complication post TURP
Experimental: study group and control group
kegel exercise
this exercise used to improve urine complication post TURP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
International Prostate Symptom Score
Time Frame: within 3 month
This tool was developed by Barry et al., (1992) for assessing LUTs after TURP. Post-TURP, patients may continue to experience urinary symptoms such as frequency, urgency, nocturia, and incomplete emptying. International Prostate Symptom Score consists of seven symptom-related questions and one quality-of-life question to assess the severity of LUTs. The symptom questions evaluate incomplete emptying, frequency, intermittency, urgency, weak stream, straining, and nocturia, each scored from 0 (never),1(less than 1time in 5), 2 (less than half the time), 3 (about half the time), 4 (more than half the time) to 5 (almost always), with a total score ranging from 0 to 35 (mild: 0-7, moderate: 8-19, severe: 20-35).
within 3 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
World Health Organization Performance Status Scale
Time Frame: within 6 month
It developed by Oken et al., (1982) to assess how disease affects daily living abilities of patient and describes the status of symptoms and functions. It consists of: Grade 0: Normal activity, Grade 1: Restricted in physical strenuous activities but ambulatory and able to carry out work of light or sedentary nature, Grade 2: Less than 50% of daytime in bed, Grade 3: More than 50% of daytime in bed, Grade 4: Completely disabled and Grade 5: Dead.
within 6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2025

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

November 1, 2026

Study Registration Dates

First Submitted

April 14, 2025

First Submitted That Met QC Criteria

April 21, 2025

First Posted (Actual)

April 29, 2025

Study Record Updates

Last Update Posted (Actual)

August 1, 2025

Last Update Submitted That Met QC Criteria

July 29, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on BPH (Benign Prostatic Hyperplasia)

Clinical Trials on Exercise

Subscribe